期刊文献+

经尿道微波针凝治疗膀胱癌 被引量:2

Transurethral microwave needle ablation of bladder cancer (report of 24 cases)
原文传递
导出
摘要 报道24例经尿道微波针凝治疗膀胱肿瘤的临床效果。结果显示:术中及术后未发生膀胱出血及膀胱穿孔,术后肿瘤部位活检未见肿瘤残留,手术时间和治疗效果与经尿道膀胱肿瘤电切术相仿,但并发症少,住院时间缩短。术后21例平均随坊4.1年,有2例非治疗部位发生肿瘤,而治疗部位无1例肿瘤复发。经尿道微波针凝具有简便、安全、不出血、有效及经济等优点,适用于无电切条件的医疗单位,其适应证为有蒂或直径≤2. Transurethral microwave needle ablation of bladder caner(TUMWNABT) was carried out for 24 patients.No residual malignant tissue was found on biopsy from the irradiated sites after the procedure .There were no bleeding and vesical perforation during and after operation.The outcome of TUMWNABT group was similar to that of TURBT group and no significant difference was found between the two techniques in operative times.However, the mean hospitalization days after treatment in TUMWNABT were fewer .21 patients have been followed up for a mean of 4.1 year .In 2 cases occurrence of tumor in non irradiated sites was found ,but no recurrence of tumor in the treated areas has been observed in all the followed up patients.Being simple,minimal bleeding,safe ,effective and economical,TUMWNABT was particularly recommended for treating bladder cancer in those hospitals where transurethral resection equipment was not available.TUMWNABT was suitable for pedicled tumor or broad based tumor of ≤2.5cm in diameter.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 1998年第6期273-275,共3页 Chinese Journal of Urology
关键词 膀胱肿瘤 微波疗法 针凝治疗 Bladder neoplasms Carcinoma Microwave
  • 相关文献

参考文献3

  • 1郭应禄,腔内泌尿外科学(第2版),1995年,97页
  • 2钱松溪,中华泌尿外科杂志,1990年,11期,235页
  • 3钱松溪,中华泌尿外科杂志,1989年,10期,89页

同被引文献23

  • 1徐继恩,张关富.丝裂霉素C膀胱内灌注预防浅表性膀胱癌术后复发[J].临床泌尿外科杂志,1993,8(2):72-74. 被引量:17
  • 2黄继先,张德元,张弓长.经尿道微波组织凝固治疗膀胱癌[J].中华外科杂志,1995,33(8):500-501. 被引量:2
  • 3[1]Brendler CB,Steiberg GD,Marshall FF,et al. Local recurrence and survival following nerve-sparing radical cystoprotectomy[J]. J Urol,1990,144:1137.
  • 4[2]Hautmann RE, Paiss T. Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy?[J]. J Urol, 1998,159:1845-1850.
  • 5[4]Herr HW, Bajorin DF, Scher HI. Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome[J]. J Clin Oncol, 1998, 16:1298-1301.
  • 6[6]Zietman AL, Shipley WU, Kaufman DS, et al. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer[J]. J Urol, 1998,160:1673-1677.
  • 7[12]Sternberg CN, Yagoda A,Scher HI,et al. Methotrexate, vinblastine, doxorubicin and cisplatin for advanced transitional cell carcinoma of the urothelium:efficacy,paterns of response and relapse[J]. Cancer,1998,142:289.
  • 8[13]Serretta V, Lo Greco G, Pavone C, et al. The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience[J]. J Urol, 1998 , 159:1187-1191.
  • 9[14]Roth BJ,Bajorin DF. Advanced bladder cancer:The need to identify new agents in the post-M-VAC world[J]. J Urol,1995,153:894.
  • 10[16]Mokarim A,Uetani M,Sakamoto I,et al. Transarterial infusion of cisplatin and doxorubicin in bladder cancer[J]. Acta Oncol, 1997, 36:175-181.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部